Flagship Pioneering Inc. raised its holdings in shares of Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Free Report) by 30.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,293,848 shares of the company’s stock after acquiring an additional 300,000 shares during the quarter. […]
Avidity Partners Management LP increased its position in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Free Report) by 5.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,673,538 shares of the company’s stock after purchasing an additional 92,396 shares during the […]
Shares of Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $5.25 and traded as low as $4.99. Syros Pharmaceuticals shares last traded at $5.00, with a volume of 68,625 shares trading hands. Analyst Upgrades and Downgrades […]
HC Wainwright restated their buy rating on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently has a $15.00 price target on the stock. HC Wainwright also issued estimates for Syros Pharmaceuticals’ Q2 2024 earnings at ($0.73) EPS, Q3 2024 earnings at ($0.74) EPS, Q4 […]
Syros Pharmaceuticals (NASDAQ:SYRS) Issues Quarterly Earnings Results, Beats Expectations By $0.10 EPS modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.